- Home
- MNTK vs RCKT Comparison
MNTK vs RCKT Comparison
Compare MNTK & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- RCKT
- Stock Information
- Founded
- MNTK 1980
- RCKT 1999
- Country
- MNTK United States
- RCKT United States
- Employees
- MNTK N/A
- RCKT N/A
- Industry
- MNTK Natural Gas Distribution
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MNTK Utilities
- RCKT Health Care
- Exchange
- MNTK Nasdaq
- RCKT Nasdaq
- Market Cap
- MNTK 306.2M
- RCKT 328.6M
- IPO Year
- MNTK 2021
- RCKT N/A
- Fundamental
- Price
- MNTK $2.07
- RCKT $3.28
- Analyst Decision
- MNTK Hold
- RCKT Buy
- Analyst Count
- MNTK 3
- RCKT 13
- Target Price
- MNTK $3.33
- RCKT $12.96
- AVG Volume (30 Days)
- MNTK 193.1K
- RCKT 5.9M
- Earning Date
- MNTK 08-06-2025
- RCKT 11-06-2025
- Dividend Yield
- MNTK N/A
- RCKT N/A
- EPS Growth
- MNTK N/A
- RCKT N/A
- EPS
- MNTK 0.02
- RCKT N/A
- Revenue
- MNTK $181,341,000.00
- RCKT N/A
- Revenue This Year
- MNTK $3.74
- RCKT N/A
- Revenue Next Year
- MNTK $3.88
- RCKT $108.43
- P/E Ratio
- MNTK $111.68
- RCKT N/A
- Revenue Growth
- MNTK N/A
- RCKT N/A
- 52 Week Low
- MNTK $1.68
- RCKT $2.19
- 52 Week High
- MNTK $6.04
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- MNTK 47.00
- RCKT 51.09
- Support Level
- MNTK $2.04
- RCKT $3.16
- Resistance Level
- MNTK $2.26
- RCKT $3.40
- Average True Range (ATR)
- MNTK 0.10
- RCKT 0.27
- MACD
- MNTK 0.00
- RCKT -0.01
- Stochastic Oscillator
- MNTK 33.33
- RCKT 32.79
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.